MedPath

Combined Spinal-Epidural Temperature and Duration of Action

Phase 2
Completed
Conditions
Pain
Interventions
Drug: combined spinal epidural
Registration Number
NCT02020304
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The hypothesis is that a combined spinal-epidural drug at refrigerated temperature will have a shorter period of pain relief than that maintained at room temperature. The temperature of the dose of medication will be measure with an infrared thermometer immediately prior (within 5 minutes) to administration.

Detailed Description

Subjects will receive a combined spinal epidural medication as per standard of care to treat their labor pain; however, they will be randomized to receive either a dose maintained at room temperature (60-75 degrees F) or one maintained in a refrigerator (\~\<43 degrees F). Duration of action will be done by assessments of pain, vital signs, nausea, itching, bromage and fetal heart rate every 15 minutes until the subject requests additional pain medication to treat their labor pain.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
58
Inclusion Criteria
  • >/= 18 years of age not allergic to medications used to treat labor pain </= 6cm cervical dilation visual pain score >/=3
Read More
Exclusion Criteria
  • <18 years of age > 6 cm cervical dilation non-English speaking subjects
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Room temperaturecombined spinal epiduralroom temperature combined spinal epidural dose (60-75 degrees F)
refrigerated temperaturecombined spinal epiduralrefrigerated temperature combined spinal epidural dose (\~\<43 degrees F)
Primary Outcome Measures
NameTimeMethod
Timeup to 3 hours

length of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\~1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.

Secondary Outcome Measures
NameTimeMethod
Analgesia Onset-5 Minutes Post Injectionfrom time of CSE administration
Analgesia Onset-10 Minutes Post Injectionup to 3 hours
Analgesia Onset-15 Minutes Post Injectionup to 3 hours
Pruritus30 minutes

patients reporting pruritis at 30 minutes after CSE injection, self reported and measured on a scale of 0 (no itching at all) up to 10 (itching as bad as can be imagined)

Trial Locations

Locations (1)

Forsyth Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath